title: Urinary liver-type fatty acid-binding protein and progression of diabetic nephropathy in type 1 diabetes.
abstract: OBJECTIVE
  Diabetic nephropathy (DN) has mainly been considered a glomerular disease, although tubular dysfunction may also play a role. This study assessed the predictive value for progression of a tubular marker, urinary liver-type fatty acid-binding protein (L-FABP), at all stages of DN.
  
  
  METHODS
  At baseline, 1,549 patients with type 1 diabetes had an albumin excretion rate (AER) within normal reference ranges, 334 had microalbuminuria, and 363 had macroalbuminuria. Patients were monitored for a median of 5.8 years (95% CI 5.7-5.9). In addition, 208 nondiabetic subjects were studied. L-FABP was measured by ELISA and normalized with urinary creatinine. Different Cox proportional hazard models for the progression at every stage of DN were used to evaluate the predictive value of L-FABP. The potential benefit of using L-FABP alone or together with AER was assessed by receiver operating characteristic curve analyses.
  
  
  RESULTS
  L-FABP was an independent predictor of progression at all stages of DN. As would be expected, receiver operating characteristic curves for the prediction of progression were significantly larger for AER than for L-FABP, except for patients with baseline macroalbuminuria, in whom the areas were similar. Adding L-FABP to AER in the models did not significantly improve risk prediction of progression in favor of the combination of L-FABP plus AER compared with AER alone.
  
  
  CONCLUSIONS
  L-FABP is an independent predictor of progression of DN irrespective of disease stage. L-FABP used alone or together with AER may not improve the risk prediction of DN progression in patients with type 1 diabetes, but further studies are needed in this regard.
authors: Second Clinical Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania.
authors: Nicolae M
authors: NM
authors: Panduru
authors: Carol
authors: C
authors: Forsblom
authors: Markku
authors: M
authors: Saraheimo
authors: Lena
authors: L
authors: Thorn
authors: Angelika
authors: A
authors: Bierhaus
authors: Per M
authors: PM
authors: Humpert
authors: Per-Henrik
authors: PH
authors: Groop
mesh_terms: D000328:Adult; D000419:Albuminuria / Q000652:urine; D003922:Diabetes Mellitus, Type 1 / Q000473:pathology* / Q000652:urine*; D003928:Diabetic Nephropathies / Q000473:pathology* / Q000652:urine*; D050556:Fatty Acid-Binding Proteins / Q000652:urine*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D050556:Fatty Acid-Binding Proteins
references: Am J Pathol. 2004 Oct;165(4):1243-55
references: 15466390
references: Nephron Clin Pract. 2009;112(3):c148-56
references: 19390215
references: Diabetes Care. 2009 Sep;32(9):1684-8
references: 19502542
references: Diabetes Care. 2010 Jun;33(6):1320-4
references: 20185732
references: Am J Nephrol. 1993;13(5):385-98
references: 8116691
references: Lancet. 1982 Jun 26;1(8287):1430-2
references: 6123720
references: Diabetologia. 2006 Jun;49(6):1183-9
references: 16609874
references: Diabetes Care. 2010 Jul;33(7):1536-43
references: 20413518
references: Diabetes Care. 2009 May;32(5):950-2
references: 19196885
references: Clin Chim Acta. 2012 Jan 18;413(1-2):187-91
references: 21958699
references: Diabetes Care. 2005 Aug;28(8):2019-24
references: 16043748
references: Clin Sci (Lond). 1993 Nov;85(5):557-62
references: 8287643
references: Kidney Int. 2002 Nov;62(5):1628-37
references: 12371963
references: Biochem J. 1992 Nov 15;288 ( Pt 1):285-90
references: 1280113
references: Nat Clin Pract Nephrol. 2008 Apr;4(4):216-26
references: 18268525
references: Mol Cell Biochem. 2006 Mar;284(1-2):175-82
references: 16532260
references: Eur J Clin Invest. 2010 Feb;40(2):95-102
references: 19912308
references: J Am Soc Nephrol. 2007 Nov;18(11):2894-902
references: 17942962
references: Diabetes Care. 2005 Nov;28(11):2728-32
references: 16249547
references: BMJ. 1992 Oct 31;305(6861):1051-3
references: 1467683
references: Am J Nephrol. 2005 Sep-Oct;25(5):447-50
references: 16118482
references: Diabetes Care. 2011 Mar;34(3):691-6
references: 21273494
references: Diabetologia. 2007 Feb;50(2):490-2
references: 17171364
references: Kidney Int. 2010 Apr;77(8):708-14
references: 19940842
references: J Am Soc Nephrol. 2008 Feb;19(2):269-80
references: 18057217
references: Am J Kidney Dis. 2007 Nov;50(5):721-32
references: 17954285
references: Am J Med Sci. 2007 Jun;333(6):321-6
references: 17570983
references: QJM. 1994 Oct;87(10):601-7
references: 7987655
references: Am J Kidney Dis. 2008 Mar;51(3):395-406
references: 18295055
references: Diabetes. 2009 Jul;58(7):1651-8
references: 19401416
references: J Am Soc Nephrol. 2011 Mar;22(3):537-44
references: 21335512
references: Eur J Intern Med. 2009 Oct;20(6):551-5
references: 19782912
references: Diabetes. 1994 Nov;43(11):1358-64
references: 7926312